NV-03

N/A

Report date: 2024/12/17 09:31:05
NME

Base Information

Drug NameNV-03
Drug Alias NameNV-03
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionE3 ubiquitin-protein ligase UHRF1 inhibitors
TargetsE3 ubiquitin-protein ligase UHRF1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Toronto, Toronto
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Toronto, Toronto
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A